Combination Products

Drug-device combination products continue to drive innovative solutions for administering therapies to patients. However, the increasingly complex nature of these devices can make it challenging to develop a preclinical safety testing strategy and plan that meets regulatory requirements for both the drug and device.

WuXi AppTec Laboratory Testing Division Medical Device Platform’s experience in devices, pharmaceuticals and biologics provides customers with a comprehensive solution to achieving preclinical safety. After years of experience with hundreds of combination products, we know that each combination product is different and needs a plan to meet the expectations of global regulatory bodies.